Rare diseases
Investigational molecules
Locations
730 3rd Avenue Floor 9, 10017-3206, United States
Clinical research in acute myeloid leukemia, including newly diagnosed AML with NPM1 mutation and relapsed or refractory acute leukemias, with attention to disease control, remission outcomes, and treatment response in genetically defined subgroups.
Interest extends to measurable residual disease clearance, complete remission, and event-free survival in combination with intensive chemotherapy.
Syndax Pharmaceuticals Inc. runs clinical trials in conditions such as Acute myeloid leukaemia, Acute leukaemia, Chronic graft versus host disease, Idiopathic pulmonary fibrosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
France
BelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
